sr 11237 has been researched along with silicon in 1 studies
| Studies (sr 11237) | Trials (sr 11237) | Recent Studies (post-2010) (sr 11237) | Studies (silicon) | Trials (silicon) | Recent Studies (post-2010) (silicon) |
|---|---|---|---|---|---|
| 26 | 0 | 9 | 13,461 | 71 | 6,740 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antony, P; Burschka, C; Gaudon, C; Götz, K; Gronemeyer, H; Ivanova, D; Kaupp, M; Lippert, WP; Moras, D; Rochel, N; Sato, Y; Tacke, R | 1 |
1 other study(ies) available for sr 11237 and silicon
| Article | Year |
|---|---|
Silicon analogues of the RXR-selective retinoid agonist SR11237 (BMS649): chemistry and biology.
Topics: Benzoates; Binding Sites; Cell Line, Tumor; Computer Simulation; Crystallography, X-Ray; HeLa Cells; Humans; Recombinant Proteins; Retinoid X Receptors; Retinoids; Silicon; Static Electricity | 2009 |